Trial intelligence / Profile preview

Oral tranexamic acid versus placebo for bleeding reduction during spinal surgery

IRCT20120215009014N506Phase 3Completed

Sponsor
Hamadan University of Medical Sciences
Start
Apr 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Bleeding comparing Tranexamic acid plus routine preoperative care with Placebo plus routine preoperative care (2 arms). Primary endpoints: Hemoglobin level, Volume of blood lost and 1 more. Started Apr 2024; status: completed.

02

Drugs

tranexamic acid
03

Conditions

Bleeding

Beyond the preview

Go deeper on IRCT20120215009014N506.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120215009014N506.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call